메뉴 건너뛰기

XEDITION

등업게시판

Lilly sees 2024 profit above estimates, shares spike



Palantir shares soar on AI revenue boost



DuPont sets $1 bln stock buyback target, hikes dividend

*

Indexes: Dow up 0.34%, S&P up 0.19%, Nasdaq up 0.11%

(Updated at 9:53 a.m. ET/ 1453 GMT)

By Johann M Cherian and Ankika Biswas

Feb 6 (Reuters) - Wall Street's main indexes inched higher on Tuesday as investors parsed big-ticket earnings and awaited commentary from policymakers for clues on the timing of the Federal Reserve's first interest-rate cut.

Eli Lilly jumped 3.5% after forecasting 2024 profit above estimates, driven by demand for its blockbuster weight-loss drug Zepbound and diabetes medicine Mounjaro.

GE HealthCare Technologies gained 8.0% after the medtech firm posted better-than-expected fourth-quarter earnings.

The S&P 500 healthcare sector was up 0.6%, scaling a record high. The materials index gained 1.4%, as chemicals firm DuPont de Nemours jumped 6% after beating fourth-quarter profit estimates, announcing a new $1 billion share-repurchase program and hiking its dividend.

With around half of the S&P 500 companies having reported earnings, 80.4% have surpassed expectations, according to LSEG data last week. Overall S&P 500 earnings are now expected to have risen 7.8% in the fourth quarter from the year-ago quarter.

Investors are actively monitoring forecasts from businesses against a backdrop of high borrowing costs and persistent slowdown concerns.

"Companies are telling us they see growth in six months to a year out and it could be growth in earnings or in the top line. But it's definitely growth, and it's not the recession that people were looking for last year," said Kim Forrest, chief investment officer at Bokeh Capital Partners.

"Certainly there have been winners and losers in certain categories, but overall, we're getting an economy that's growing."

Wall Street started the week on a glum note in the previous session on the heels of a blistering rally in the S&P 500, which notched 13 weekly gains out of 14. The benchmark index was aided by largely positive corporate earnings and optimism that a rate cut might be imminent.

However, Fed officials, including Chair Jerome Powell, have actively talked down market expectations of a quick start to policy easing, a key theme in the central bank's interest-rate decision last week. Strong labor market and economic activity data have also fed into rate-cut anxieties.

Remarks from the Fed's policymakers through the day, including voting member Cleveland's Loretta Mester, will be on investors' watch list.

Traders are betting with a nearly 65% chance that at least a 25-basis-point rate cut could be delivered in May, with the odds standing at around 94% for the first cut in June, according to the CME FedWatch Tool.

At 9:53 a.m. ET, the Dow Jones Industrial Average was up 130.09 points, or 0.34%, at 38,510.21, the S&P 500 was up 9.50 points, or 0.19%, at 4,952.31, and the Nasdaq Composite was up 16.48 points, or 0.11%, dark web at 15,614.16.

Palantir Technologies jumped 26.3% after the data analytics firm forecast annual profit above estimates, while FMC Corp tumbled 8.1% after forecasting downbeat first-quarter profit.

Gartner lost 2.9% after the research and advisory firm forecast annual results below estimates.

Advancing issues outnumbered decliners by a 3.23-to-1 ratio on the NYSE and by a 2.19-to-1 ratio on the Nasdaq.

The S&P index recorded 14 new 52-week highs and eight new lows, while the Nasdaq recorded 42 new highs and 57 new lows. (Reporting by Johann M Cherian and Ankika Biswas in Bengaluru; Editing by Pooja Desai)

번호 제목 글쓴이 날짜 조회 수
공지 esky에 오신걸 환영합니다. 관리자 2024.12.09 33
7073 FALSE:: MISTAKE: UNSUPPORTED ENCODING StevieParramore094 2025.07.19 204
7072 Top 13 Best Fisetin Supplements GlindaSlattery8449 2025.07.19 3
7071 A Senolytic Antioxidant For Healthy And Balanced Aging And More KristinHornung633176 2025.07.19 2
7070 NAD Supplement Benefits, Makes Use Of And Dose Recommendations BrockGcp923177881 2025.07.19 2
7069 FALSE:: MISTAKE: UNSUPPORTED ENCODING RoscoeWilbanks9 2025.07.19 15
7068 Urolithin A Vs Pomegranate Remove Archives. AdolphLefebvre4 2025.07.19 3
7067 Dosages And Just How To Take It SammieBrannon258 2025.07.19 3
7066 Our Group. EAP In The Media. CortneyStreeter4105 2025.07.19 2
7065 What Do They Do For You? BrittneyFranki97101 2025.07.19 3
7064 8 Best NMN Supplements Of 2024. ShelliVallecillo61 2025.07.19 2
7063 Frequently Asked Inquiries. MeghanZfc39386755 2025.07.19 2
7062 Economics Concepts Videos By The Economics Tutor. OlivaMount2938844 2025.07.19 2
7061 Top 5 NMN Brands In 2023 RosieCatalan4650 2025.07.19 3
7060 Professional Pay Per Click Provider. TamaraHartmann107477 2025.07.19 3
7059 FALSE:: ERROR: UNSUPPORTED ENCODING SilkeFda4142310302 2025.07.19 28
7058 Concerning Autism In Your Home Autism In The House. DelmarGillott59549 2025.07.19 2
7057 CBD Softgels (10mg & 25mg) LeonardoChandler641 2025.07.19 2
7056 Advantages, Makes Use Of And Dose AntoniaDennys022 2025.07.19 2
7055 Cu) Benefits, Outcomes, And Threats CharityStearns706 2025.07.19 2
7054 Fisetin Prospective Perks Foods, Dosage & Side Impacts PorterStrunk129034 2025.07.19 2
위로